Zydus spies opportunities in Brazil and Mexico along with biosimilars

Zydus Cadila sees Brazil and Mexico as future "home markets" and anticipates large contributions from these growth zones in the next few years, during which it appears set to build up its biosimilars pipeline in India.

More from Anti-infective

More from Therapeutic Category